Therapy insight: Therapeutic challenges in the treatment of elderly cancer patients: Commentary Review uri icon

Overview

MeSH Major

  • Antineoplastic Agents
  • Life Expectancy
  • Neoplasms

abstract

  • People over the age of 65 years constitute the fastest-growing segment of the US population. Within the next 30 years, this group will comprise over 20% of the total population. Importantly, 50% of all cancers and 70% of cancer mortality occur in this age group. Choosing the correct chemotherapy regimen and dose for the older patient can be extremely difficult because of physiological changes that occur with aging, as well as other comorbidities associated with this age group. Treatment decisions need to be based on a patient's individual performance, functional status and life expectancy. Although there are no accepted algorithms to guide management decisions in elderly cancer patients, data are becoming available that will help guide the use of chemotherapy in the older patient population.

publication date

  • February 2006

Research

keywords

  • Review

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1038/ncponc0420

PubMed ID

  • 16462849

Additional Document Info

start page

  • 86

end page

  • 93

volume

  • 3

number

  • 2